Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Cadus Pharmaceutical Corp. (KDUS) -- Ignore unavailable to you. Want to Upgrade?

To: scaram(o)uche who wrote (171)	5/7/2000 6:50:00 AM
From: dalroi	Read Replies (1) \| Respond to of 1833

Nice to comperare with previous statement AMOUNT AND NATURE PERCENTAGE OF OUTSTANDING NAME AND ADDRESS OF BENEFICIAL OWNER(1) BENEFICIAL OWNERSHIP OWNED(2) ------------------------------------------------------------------- -------------------- ------------------------- Carl C. Icahn ................................................... 3,367,216(3) 25.75% 767 Fifth Avenue New York, New York 10153 Bristol-Myers Squibb .............................................. 2,061,673 15.78% P.O. Box 4000 Route 206 and Province Line Road Princeton, New Jersey 08543-4000 Physica B.V. (4) .................................................. 1,599,942 12.24% C.J. van Houtenlaan 36 1381 CP Weesp The Netherlands International Biotechnology Trust plc ............................. 850,000(5) 6.50% c/o Rothschild Asset Management Limited Five Arrows House St. Swithins Lane London EC4N 8NR United Kingdom SmithKline Beecham Corporation .................................... 660,962(6) 5.06% One Franklin Plaza Philadelphia, PA 19102 Charles Woler ................................................... * * Philip N. Sussman.................................................. 137,363(7) 1.04% David R. Webb, Ph.D................................................ 72,917(8) * Arlindo L. Castelhano, Ph.D........................................ 22,334(9) * James S. Rielly.................................................... 15,618(10) * Jeremy M. Levin, D. Phil., MB. BCHIR............................... 290,071(11) 2.17% Theodore Altman*.................................................. 6,000(12) James R. Broach.................................................. 203,668(13) 1.55% Harold First..................................................... 16,834(14) * Russell D. Glass*................................................. -- William H. Koster, Ph.D............................................ 2,061,673(15) 15.78% Peter S. Liebert, M.D.*........................................... 14,334(16) Robert J. Mitchell*............................................... 6,000(17) Siegfried G. Schaefer, Ph.D...................................... 1,599,942(18) 12.24% Nicole Vitullo................................................... 8,500(19) * Samuel D. Waksal, Ph.D.*.......................................... 6,000(20) Jack G. Wasserman*................................................ 8,500(21) 2 NUMBER OF SHARES AMOUNT AND NATURE PERCENTAGE OF OUTSTANDING NAME AND ADDRESS OF BENEFICIAL OWNER(1) BENEFICIAL OWNERSHIP OWNED(2) ------------------------------------------------------------------- ---------- ----- All executive officers and directors as a group (17 persons)....... 7,836,970